© TheStreet Cannabis Stocks Watchlist: When to Buy Canopy Growth
Joe Biden will be inaugurated as the 46th President on Wednesday and investors are looking for investment opportunities to prepare for the Biden Presidency. Cannabis is one of the sectors that could benefit from Biden’s policy platform.
Could that platform include federally decriminalizing cannabis and legalizing it for recreational use as states like Colorado, Massachusetts and California have done already?
If you’re looking for the best stocks to invest in in the cannabis sector, TheStreet’s Debra Borchardt recently shared her top stock picks in the cannabis sector for 2021.
Here is a list of the cannabis stocks to watch and their performance from this past week by the percentage change at the close of trading on Jan 8.
Aurora Cannabis Inc | Increased +13.41% | Price $11.84
Marijuana Business Daily is reporting more layoffs at Aurora Cannabis following the Great North Deal.
TheStreet Quant Ratings rates Aurora Cannabis Inc. as a Sell with a rating score of D-.
Aphria Inc. | Increased +45.09% | Price $12.42
Aphria and Tilray both surged higher this past week and Aphria just received a price target upgrade by Stifel.
Video: Why small caps will outperform in 2021, according to market analyst (CNBC)
Why small caps will outperform in 2021, according to market analyst
What to watch next
How you can save $1 million for retirement
USA TODAY
How much the most populous states pay mail carriers
GOBankingRates
Creepy ways your company can spy on you while you work from home
Veuer
Major companies suspend social media advertising over online hate speech
CBS News
Women and retirement planning
Money Talks News
This bookshop survived earthquakes and recessions. But not this
CNN Money
Jim Cramer on Chesapeake Energy filing for bankruptcy
CNBC
Should you save for retirement or pay down debt?
Money Talks News
Ford just unveiled its 2021 tech-savvy pickup — here’s what’s new
CNBC
Amazon looking to get into the self-driving car business buys startup for $1B
Veuer
Economic outlook as more Americans file for unemployment
CBS News
5 items you can sell for additional income
GOBankingRates
5 practical reasons to put purchases on credit
GOBankingRates
How to prepare for the next recession
Money Talks News
Disney World workers petition to delay reopening of theme park
CNBC
500 Delta staff have tested positive for COVID-19 and 10 have died
Veuer
How you can save $1 million for retirement How you can save a million bucks for retirement USA TODAY
How much the most populous states pay mail carriers Americans rely on mail carriers to send and receive their mail. Have you ever wondered how much these essential workers make? GOBankingRates
Creepy ways your company can spy on you while you work from home Just because you’re working from home doesn’t mean your boss can’t keep tabs on your every move. Veuer’s Sean Dowling has more. Veuer
UP NEXT
TheStreet Quant Ratings rates Aphria as a Sell with a rating score of D.
Tilray Inc | Increased +55.31% | Price $19.15
Tilray surged this past week as it benefits from the merger deal with Aphria.
TheStreet Quant Ratings rates Tilray as a Sell with a rating score of D-.
Canopy Growth Corp | Increased +6.45% | Price $33.50
Canopy Growth filed an early warning report this past week in connection with the acquisition of an option to purchase 1,072,450 common shares of TerrAscend Corp.
Real Money writer Bruce Kamich looked at the charts for Canopy Growth to see how investors should trade.
TheStreet Quant Ratings rates Canopy Growth Corp as a Hold with a rating score of C.
GW Pharma | Increased +5.87% | Price $135.73
GW Pharma says it expects sales to reach $526 million according to Hemp Industry Daily.
TheStreet Quant Ratings rates GW Pharma as a Sell with a rating score of D+.
Cronos Group CRON | Increased +11.33% | Price $10.91
Cronos Group was downgraded by Zacks Investment Research to “Hold” on Monday according to Market Beat.
TheStreet Quant Ratings rates Cronos Group as a Hold with a rating score of C.
NOTE: Recently, Quantitative Analysis by TheStreet Quant Ratings objectively rated these stocks according to its risk-adjusted total return prospect over a 12-month investment horizon. Not based on the news on any given day, the rating may differ from Jim Cramer’s view or that of this articles’ author.
This article was originally published by TheStreet.
Recent Comments